Max Healthcare profit jumps 7%, to raise INR 42 billion in debt
Max Healthcare, one of India’s largest private hospital chains, reported a 7% rise in profit after tax, on revenue of INR 15.6 billion,.
Drugs
Medical
Pharma
Health
Medical
Pharma
Junk food increase ovarian, brain cancer risk: UK study
Fizzy drinks, mass-produced breads, many ready meals, and most breakfast cereals increase the risk of cancer as they contain higher salt, fat, sugar.
Drugs
Medical
Pharma
12 African nations commit to end AIDS in children by 2030
Twelve African nations have drawn out a blueprint to stop AIDS in children by 2030, a move welcomed by the United Nations.
Drugs
Health
Pharma
Stelis Biopharma to be pure play CDMO firm, may list ‘near term’
Stelis Biopharma, a division of India’s Strides Pharma Science, will become a full-fledged contract development and manufacturing firm and may list “near-term.
Drugs
Medical
Pharma
China’s lifting of COVID-19 curbs to ease supply chain disruptions: Glenmark
Glenmark Pharmaceuticals, an Indian global drug maker with a focus on dermatology, respiratory and oncology areas, forecasts lifting of China's COVID-19 curbs may.
Drugs
Pharma
India’s pharma market to be worth $130 billion by 2030
The Indian pharmaceutical market is estimated to be worth $130 billion by 2030 from an estimated US$ 41 billion in 2021, the Economic.
Drugs
Pharma
Syngene buys Hyderabad operations in slump sale value of INR 4 billion
Syngene's operations in the Indian city of Hyderabad have been transferred to another wholly-armed arm of the company with effect from April 1,.
Health
Medical
Pharma
U.S. to end Covid-19 curbs on May 11, migrant policy remains same
The U.S. plans to end COVID-19 emergency restrictions by May 11, according to a statement by the Office of Management and Budget.
Drugs
Medical
Pharma
Lupin gets tentative nod for three HIV drugs
Lupin, headquartered in Mumbai, India, has received tentative approval from the FDA under the US President’s Emergency Plan for AIDS Relief for its.
Drugs
Medical
Pharma
No ‘directed evolution research’ in COVID-19 vaccine: Pfizer
Pfizer refuted allegations by Project Veritas, a media organization, in its ongoing COVID-19 vaccine work stating it has “not conducted gain-of-function” or “directed.